MAY 19, 2022 11:00 AM PDT

Vaccine for Deadly Mosquito-borne Virus Shows Promising Trial Results

WRITTEN BY: Ryan Vingum

Eastern equine encephalitis virus (EEEV), Western equine encephalitis (WEEV), Venezuelan equine encephalitis (VEEV) are all viruses causing rare infections that are spread from mosquitoes to humans. So rare, in fact, that the United States records only about 11 cases each year. Horses, while unable to spread the infection to humans, can also be infected by these viruses.

While rare in humans, these infections can be deadly. In most cases, the viruses cause flu-like symptoms. There isn’t a specific treatment used beside letting the body fight the virus. In severe cases, however, neurological damage or death can occur. Because of these potentially fatal risks, the virus can be more dangerous for people in certain situations where the chances of contracting the virus are higher, such as military personnel. 

To make matters worse, under certain circumstances, these viruses can be manipulated to spread through the air, making them biological agents requiring close scrutiny from a national security perspective. The National Institutes of Allergy and Infectious Diseases (NIAID) is addressing this risk, in the form of a vaccine. Their work is presented in a recent paper published in Lancet Infectious Diseases.

The vaccine developed by NIAID researchers is a virus-like particle vaccine. This type of vaccine uses materials that look just like the virus the vaccine is designed to protect against. However, these virus look-alikes do not have the genetic material needed to replicate. The virus-like particles also have proteins on their surfaces similar to proteins on EEEV, WEEV, and VEEV, which is designed to elicit a response from the immune system.

The Phase 1 trial to test the vaccine's initial safety showed some promising results. Thirty volunteers between the ages of 18 and 50 received a dose of the vaccines through an injection, and then a booster dose about eight weeks later. Overall, the vaccine appeared to be safe, was tolerated well by participants, and generated an immune response in the form of neutralizing antibodies.

The evidence suggests that the vaccine should be further studied in clinical trials.

Sources: Science Daily; Lancet Infectious Diseases

About the Author
Professional Writing
Science writer and editor, with a focus on simplifying complex information about health, medicine, technology, and clinical drug development for a general audience.
You May Also Like
APR 28, 2022
Drug Discovery & Development
Keto Molecule Shows Promise for Treating Colorectal Cancer
APR 28, 2022
Keto Molecule Shows Promise for Treating Colorectal Cancer
A molecule produced when on low-carbohydrate ketogenic diets suppresses the growth of colorectal tumors in the lab. The ...
MAY 09, 2022
Cancer
A Gel Implant Protects from Cancer Recurrence
MAY 09, 2022
A Gel Implant Protects from Cancer Recurrence
Following a successful course of cancer treatment, a patient may enter remission. Remission, classified as either partia ...
MAY 19, 2022
Drug Discovery & Development
Repurposed Antibiotic Shows Promise Against COVID-19 in Mice
MAY 19, 2022
Repurposed Antibiotic Shows Promise Against COVID-19 in Mice
An antibiotic known as clofoctol has shown promise in treating SARS-CoV-2 in mice. The corresponding study was published ...
JUN 10, 2022
Cannabis Sciences
Are Cannabis Users Nicer?
JUN 10, 2022
Are Cannabis Users Nicer?
A study published in Nature offers evidence that cannabis has a positive effect on the psychosocial health of young adul ...
JUN 22, 2022
Cell & Molecular Biology
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
JUN 22, 2022
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
Introduction Centrifugation and filtration have been widely accepted as techniques required for clarifying complex cell ...
JUN 26, 2022
Drug Discovery & Development
Acupuncture Alleviates Chronic Tension Headaches in Randomized Controlled Trial
JUN 26, 2022
Acupuncture Alleviates Chronic Tension Headaches in Randomized Controlled Trial
Results from a randomized controlled trial suggest that acupuncture may relieve symptoms of chronic tension-type headach ...
Loading Comments...